Status:
COMPLETED
Formulation Comparison in Normal Volunteers
Lead Sponsor:
Aerie Pharmaceuticals
Conditions:
Normal Volunteers
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This is a double-masked, single-center, crossover study in which normal volunteers will be randomized to receive one of two formulations of 0.5% AR-12286 Ophthalmic Solution for 8 days. Subjects will ...
Detailed Description
Not desired.
Eligibility Criteria
Inclusion
- Normal volunteers
Exclusion
- Active ophthalmic or systemic disease
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT01250197
Start Date
November 1 2010
End Date
December 1 2010
Last Update
December 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Celerion
Phoenix, Arizona, United States, 85283